Biohaven Pharmaceutical Holding (BHVN) stock forecast for 2025

The forecast has been updated: March 24, 2023 9:28


Biohaven Pharmaceutical Holding stock price online today

Analyst Target Price

24.2

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Biohaven Pharmaceutical Holding stock stock today? What is the projected target price level for 2025? How much will it cost in 2025? Biohaven Pharmaceutical Holding stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2025.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $24.2 target price for Biohaven Pharmaceutical Holding stock stock.

Today 200 Day Moving Average is the resistance level (14.71 $).

50 Day Moving Average is the resistance level (16.37 $).




BHVN Forecast for 2025

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 12.51 12.24 13.47 9.19 %
Feb 11.48 10.71 12.31 13.02 %
Mar 11.30 10.54 11.74 10.17 %
Apr 10.77 10.18 11.03 7.73 %
May 11.87 11.57 12.57 7.99 %
Jun 12.54 12.15 12.92 5.98 %
Jul 11.71 11.30 12.57 10.14 %
Aug 12.11 11.69 12.56 6.89 %
Sep 10.78 9.98 11.01 9.36 %
Oct 9.91 9.69 10.39 6.71 %
Nov 10.97 10.56 11.85 10.90 %
Dec 12.08 11.77 12.72 7.42 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Biohaven Pharmaceutical Holding stock.


Biohaven Pharmaceutical Holding overview

Biohaven Pharmaceutical Holding Address

215 CHURCH STREET, NEW HAVEN, CT, US

Market Capitalization

882 003 000 $

EBITDA

-403 704 000

PE Ratio

None

PEG Ratio

None

Dividend Per Share

0

Dividend Yield

0

EPS

-10.53

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0

Trailing PE

-

Forward PE

-

EV To Revenue

-

EV To EBITDA

-2.412

52 Week High

20.57

52 Week Low

5.54

50 Day Moving Average

16.37

200 Day Moving Average

14.71

Shares Outstanding

68161000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

Biohaven Pharmaceutical Holding stock forecast for this year


Biohaven Pharmaceutical Holding stock forecast for Jan 2025.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 12.51. Positive monthly dynamics of the instrument is expected with 9.193% volatility is expected.

Pessimistic forecast: 12.24

Optimistic: 13.47


Biohaven Pharmaceutical Holding stock forecast for Feb 2025.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 11.48. Negative monthly dynamics of the instrument is expected with 13.025% volatility is expected.

Pessimistic forecast: 10.71

Optimistic: 12.31


Biohaven Pharmaceutical Holding stock forecast for Mar 2025.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 11.30. Negative monthly dynamics of the instrument is expected with 10.168% volatility is expected.

Pessimistic forecast: 10.54

Optimistic: 11.74


Biohaven Pharmaceutical Holding stock forecast for Apr 2025.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 10.77. Negative monthly dynamics of the instrument is expected with 7.733% volatility is expected.

Pessimistic forecast: 10.18

Optimistic: 11.03


Biohaven Pharmaceutical Holding stock forecast for May 2025.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 11.87. Positive monthly dynamics of the instrument is expected with 7.995% volatility is expected.

Pessimistic forecast: 11.57

Optimistic: 12.57


Biohaven Pharmaceutical Holding stock forecast for Jun 2025.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 12.54. Positive monthly dynamics of the instrument is expected with 5.976% volatility is expected.

Pessimistic forecast: 12.15

Optimistic: 12.92


Biohaven Pharmaceutical Holding stock forecast for Jul 2025.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 11.71. Negative monthly dynamics of the instrument is expected with 10.143% volatility is expected.

Pessimistic forecast: 11.30

Optimistic: 12.57


Biohaven Pharmaceutical Holding stock forecast for Aug 2025.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 12.11. Positive monthly dynamics of the instrument is expected with 6.892% volatility is expected.

Pessimistic forecast: 11.69

Optimistic: 12.56


Biohaven Pharmaceutical Holding stock forecast for Sep 2025.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 10.78. Negative monthly dynamics of the instrument is expected with 9.364% volatility is expected.

Pessimistic forecast: 9.98

Optimistic: 11.01


Biohaven Pharmaceutical Holding stock forecast for Oct 2025.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 9.91. Negative monthly dynamics of the instrument is expected with 6.715% volatility is expected.

Pessimistic forecast: 9.69

Optimistic: 10.39


Biohaven Pharmaceutical Holding stock forecast for Nov 2025.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 10.97. Positive monthly dynamics of the instrument is expected with 10.895% volatility is expected.

Pessimistic forecast: 10.56

Optimistic: 11.85


Biohaven Pharmaceutical Holding stock forecast for Dec 2025.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 12.08. Positive monthly dynamics of the instrument is expected with 7.419% volatility is expected.

Pessimistic forecast: 11.77

Optimistic: 12.72



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 98.62 (29.03.2023) 1.55 %
AbbVie Inc.
ABBV 158 (29.03.2023) -0.16 %
Aeterna Zentaris Inc.
AEZS 2.71 (29.03.2023) 1.88 %
Allakos Inc.
ALLK 4.56 (29.03.2023) 2.70 %
Allogene Therapeutics, Inc.
ALLO 5.11 (29.03.2023) 3.86 %
Amgen Inc.
AMGN 241.03 (29.03.2023) 1.07 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 2.98 (29.03.2023) 4.20 %
Aurora Cannabis Inc.
ACB 0.6874 (29.03.2023) 1.43 %
Becton Dickinson and Company
BDX 242.93 (29.03.2023) 0.70 %
Biogen Inc.
BIIB 274.01 (29.03.2023) 1.39 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 14.03 (29.03.2023) 2.86 %
BioNTech SE
BNTX 122.97 (29.03.2023) -0.02 %
bluebird bio, Inc.
BLUE 3.26 (29.03.2023) -24.54 %
Boston Scientific Corp.
BSX 49.08 (29.03.2023) 0.99 %
Bristol-Myers Squibb Company
BMY 68.18 (29.03.2023) -0.03 %
Canopy Growth Corp.
CGC 1.81 (29.03.2023) 0.00 %
Castle Biosciences, Inc.
CSTL 22.45 (29.03.2023) 1.13 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 242.27 (04.02.2022) 0.00 %
Emergent BioSolutions Inc.
EBS 9.35 (29.03.2023) 5.06 %
Exelixis, Inc.
EXEL 18.56 (17.06.2022) 5.63 %
G1 Therapeutics, Inc.
GTHX 2.75 (29.03.2023) 4.17 %
Gilead Sciences, Inc.
GILD 81.29 (29.03.2023) 0.40 %
GlaxoSmithKline plc
GSK 35.06 (29.03.2023) -0.11 %
GoodRx Holdings, Inc.
GDRX 6.02 (29.03.2023) 2.03 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 71.14 (29.03.2023) 1.18 %
Inovio Pharmaceuticals, Inc.
INO 0.8782 (29.03.2023) 1.99 %
Johnson & Johnson
JNJ 153.31 (29.03.2023) 0.98 %
Medtronic plc.
MDT 79.07 (29.03.2023) -0.55 %
Merck & Co., Inc.
MRK 104.92 (29.03.2023) -0.58 %
Moderna, Inc.
MRNA 148.8 (29.03.2023) 1.28 %
Novartis AG
NVS 90.19 (29.03.2023) -0.84 %
Novavax, Inc.
NVAX 6.66 (29.03.2023) 8.12 %
ObsEva SA
OBSV 0.091 (29.03.2023) 7.06 %
OrganiGram Holdings Inc.
OGI 0.65 (29.03.2023) 3.27 %
Pfizer Inc.
PFE 40.25 (29.03.2023) 0.65 %
Regeneron Pharmaceuticals, Inc.
REGN 819.35 (29.03.2023) -0.92 %
Sanofi
SNY 54.45 (29.03.2023) 0.48 %
Schrodinger, Inc.
SDGR 24.63 (29.03.2023) 1.44 %
Senseonics Holdings, Inc.
SENS 0.6868 (29.03.2023) -3.43 %
Sorrento Therapeutics, Inc.
SRNE 0.35 (29.03.2023) 2.94 %
Stryker Corp.
SYK 279.03 (29.03.2023) 0.58 %
Sundial Growers Inc.
SNDL 1.57 (29.03.2023) 1.95 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.84 (29.03.2023) 0.91 %
Thermo Fisher Scientific Inc.
TMO 555.15 (29.03.2023) 0.17 %
Tilray, Inc.
TLRY 2.58 (29.03.2023) 3.20 %
UnitedHealth Group, Inc.
UNH 466.59 (29.03.2023) -1.27 %
Veeva Systems Inc.
VEEV 178.66 (29.03.2023) 1.76 %
Zomedica Corp.
ZOM 0.2081 (29.03.2023) 3.79 %
Zynerba Pharmaceuticals, Inc.
ZYNE 0.44 (29.03.2023) 4.76 %

Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808

Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.